EGFR and prostate cancer: High cholesterol-mediated upregulation of adipocyte plasma membrane-associated protein (APMAP) in cholesterol-induced lipid rafts inhibits EGFR degradation, thereby activating the extracellular-regulated protein kinase 1/2 (ERK1/2) pathway and inducing EMT in prostate cancer cells 184.